Literature DB >> 9539725

The TOR (target of rapamycin) signal transduction pathway regulates the stability of translation initiation factor eIF4G in the yeast Saccharomyces cerevisiae.

C Berset1, H Trachsel, M Altmann.   

Abstract

Initiation factor eIF4G is an essential protein required for initiation of mRNA translation via the 5' cap-dependent pathway. It interacts with eIF4E (the mRNA 5' cap-binding protein) and serves as an anchor for the assembly of further initiation factors. With treatment of Saccharomyces cerevisiae with rapamycin or with entry of cells into the diauxic phase, eIF4G is rapidly degraded, whereas initiation factors eIF4E and eIF4A remain stable. We propose that nutritional deprivation or interruption of the TOR signal transduction pathway induces eIF4G degradation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9539725      PMCID: PMC22477          DOI: 10.1073/pnas.95.8.4264

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

Review 1.  A signaling pathway to translational control.

Authors:  E J Brown; S L Schreiber
Journal:  Cell       Date:  1996-08-23       Impact factor: 41.582

2.  Nucleotide sequence of the gene encoding a 20 kDa protein associated with the cap binding protein eIF-4E from Saccharomyces cerevisiae.

Authors:  M Altmann; M Krieger; H Trachsel
Journal:  Nucleic Acids Res       Date:  1989-09-25       Impact factor: 16.971

3.  TOR controls translation initiation and early G1 progression in yeast.

Authors:  N C Barbet; U Schneider; S B Helliwell; I Stansfield; M F Tuite; M N Hall
Journal:  Mol Biol Cell       Date:  1996-01       Impact factor: 4.138

4.  Molecular characterization of the yeast PRT1 gene in which mutations affect translation initiation and regulation of cell proliferation.

Authors:  P J Hanic-Joyce; R A Singer; G C Johnston
Journal:  J Biol Chem       Date:  1987-02-25       Impact factor: 5.157

5.  Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast.

Authors:  J Heitman; N R Movva; M N Hall
Journal:  Science       Date:  1991-08-23       Impact factor: 47.728

6.  A family of cyclin homologs that control the G1 phase in yeast.

Authors:  J A Hadwiger; C Wittenberg; H E Richardson; M de Barros Lopes; S I Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

7.  Regulated import and degradation of a cytosolic protein in the yeast vacuole.

Authors:  H L Chiang; R Schekman
Journal:  Nature       Date:  1991-03-28       Impact factor: 49.962

8.  Expression of antisense RNA against initiation factor eIF-4E mRNA in HeLa cells results in lengthened cell division times, diminished translation rates, and reduced levels of both eIF-4E and the p220 component of eIF-4F.

Authors:  A De Benedetti; S Joshi-Barve; C Rinker-Schaeffer; R E Rhoads
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

9.  The selection of S. cerevisiae mutants defective in the start event of cell division.

Authors:  S I Reed
Journal:  Genetics       Date:  1980-07       Impact factor: 4.562

10.  Identification and characterization of cap-binding proteins from yeast.

Authors:  C Goyer; M Altmann; H Trachsel; N Sonenberg
Journal:  J Biol Chem       Date:  1989-05-05       Impact factor: 5.157

View more
  67 in total

Review 1.  The target of rapamycin (TOR) proteins.

Authors:  B Raught; A C Gingras; N Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

2.  TOR regulates the subcellular localization of Ime1, a transcriptional activator of meiotic development in budding yeast.

Authors:  Neus Colomina; Yuhui Liu; Martí Aldea; Eloi Garí
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

Review 3.  Staying alive: metabolic adaptations to quiescence.

Authors:  James R Valcourt; Johanna M S Lemons; Erin M Haley; Mina Kojima; Olukunle O Demuren; Hilary A Coller
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

Review 4.  Power of yeast for analysis of eukaryotic translation initiation.

Authors:  Michael Altmann; Patrick Linder
Journal:  J Biol Chem       Date:  2010-08-06       Impact factor: 5.157

5.  Reduction in ribosomal protein synthesis is sufficient to explain major effects on ribosome production after short-term TOR inactivation in Saccharomyces cerevisiae.

Authors:  Alarich Reiter; Robert Steinbauer; Anja Philippi; Jochen Gerber; Herbert Tschochner; Philipp Milkereit; Joachim Griesenbeck
Journal:  Mol Cell Biol       Date:  2010-12-13       Impact factor: 4.272

Review 6.  Signaling by target of rapamycin proteins in cell growth control.

Authors:  Ken Inoki; Hongjiao Ouyang; Yong Li; Kun-Liang Guan
Journal:  Microbiol Mol Biol Rev       Date:  2005-03       Impact factor: 11.056

7.  The Saccharomyces cerevisiae phosphatase activator RRD1 is required to modulate gene expression in response to rapamycin exposure.

Authors:  Julie Douville; Jocelyn David; Karine M Lemieux; Luc Gaudreau; Dindial Ramotar
Journal:  Genetics       Date:  2005-12-01       Impact factor: 4.562

8.  Crystal structure of the yeast eIF4A-eIF4G complex: an RNA-helicase controlled by protein-protein interactions.

Authors:  Patrick Schütz; Mario Bumann; Anselm Erich Oberholzer; Christoph Bieniossek; Hans Trachsel; Michael Altmann; Ulrich Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-07       Impact factor: 11.205

9.  Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR.

Authors:  M C Cruz; A L Goldstein; J Blankenship; M Del Poeta; J R Perfect; J H McCusker; Y L Bennani; M E Cardenas; J Heitman
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

Review 10.  Life in the midst of scarcity: adaptations to nutrient availability in Saccharomyces cerevisiae.

Authors:  Bart Smets; Ruben Ghillebert; Pepijn De Snijder; Matteo Binda; Erwin Swinnen; Claudio De Virgilio; Joris Winderickx
Journal:  Curr Genet       Date:  2010-02       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.